Navigation Links
UIC researchers find promising new targets for antibiotics
Date:8/30/2007

University of Illinois at Chicago researchers have identified new sites on the bacterial cell's protein-making machinery where antibiotics can be delivered to treat infections.

"The primary challenge of antibiotic therapy has been fighting infections caused by the pathogens which became resistant to antibiotics," says Alexander Mankin, professor and associate director of UIC's Center for Pharmaceutical Biotechnology and lead investigator of the study. "Not a single class of drugs has escaped the inevitable emergence of resistance."

At present, Mankin said, "the constant development of new drugs is the only available strategy to keep up with the ever-growing variety of antibiotic-resistant pathogens."

Mankin and his research team are looking for new vulnerable sites on bacteria where drugs can be delivered to fight the infections.

"First we need to find the target, and then the weapons can be developed," he said.

In the study, which is published in the Journal of Biological Chemistry, UIC researchers divided a ribosome -- the main apparatus within the cell that makes protein, and one of the best antibiotic targets -- into specific sections. Random genetic mutations were engineered in each area, and the researchers looked for those alterations that stopped the ribosome from making proteins.

Of the thousands of mutations tested, 77 were detrimental to the function of the ribosome. The regions where those mutations lie can be targeted by new antibiotics, which may be used to treat such diseases as tuberculosis and pneumonia, Mankin said.

"If we find drugs that can bind to these regions, they will likely kill the pathogenic cell," he said.

According to Mankin, the development of microbial genomics brought new hope for the development of antibiotics, but few successful drug candidates have been produced using this method.

An alternative approach is to "follow the lead of nature, and develop new drugs that act on the targets in the course of evolution."

"The ribosome is the perfect target," he said. "More than half of all known antibiotics arrest cell growth by interfering with the ribosomal functions and inhibiting protein synthesis. This is an innovative concept, targeting new sites in the ribosome."


'/>"/>
Contact: Sam Hostettler
samhos@uic.edu
312-355-2522
University of Illinois at Chicago
Source:Eurekalert

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. NYU researchers simulate molecular biological clock
5. Researchers reveal the infectious impact of salmon farms on wild salmon
6. Researchers identify target for cancer drugs
7. Vital step in cellular migration described by UCSD medical researchers
8. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
9. UCSD researchers maintain stem cells without contaminated animal feeder layers
10. Researchers discover molecule that causes secondary stroke
11. Researchers find missing genes of ancient organism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2019)... ... December 12, 2019 , ... Crop Enhancement ... yields, has appointed Jean Pougnier as chief business officer. Mr. Pougnier will lead ... and influencers that will position the company for maximum commercial success. As part ...
(Date:12/2/2019)... ... December 01, 2019 , ... Each year ... techniques to hit the life-science landscape. For more than a decade, our expert ... laboratories and facilitating biological discovery. This year’s crop of entries to The Scientist’s ...
(Date:11/22/2019)... , ... November 21, 2019 , ... ... Roswell Park Comprehensive Cancer Center have announced a major step forward with that ... PhD, have announced that the company, spun off from Roswell Park in 2012, ...
Breaking Biology News(10 mins):
(Date:12/18/2019)... ... 17, 2019 , ... Philadelphia IP law firm Panitch ... hired Dr. Alia Orbin, Ph.D., J.D., an experienced registered patent attorney with expertise ... prosecution of patent applications related to pharmaceutical sciences, organic and inorganic chemistry, biotechnology, ...
(Date:12/4/2019)... ... December 03, 2019 , ... A new survey by ... Teleflex, and CONMED as the overall best medical sales companies to work for in ... survey polled over 1,200 professionals from the MedReps community to identify which medical ...
(Date:12/4/2019)... Lafayette, Indiana (PRWEB) , ... December 04, 2019 ... ... improved strategy to further enhance dissolution and stabilize amorphous materials. Additionally, their PDF ... and enhance the ability to describe these compositions both in regulatory and patent ...
(Date:11/22/2019)... ... November 22, 2019 , ... Modality Solutions, ... cold chain validation guide to meet and exceed increasingly stringent regulatory expectations ... biopharmaceutical industry leaders, the September 19, 2019 webinar was well received and ...
Breaking Biology Technology: